China predicts windfall in Monkeypox test kit sales

Manufacturers of diagnostic tests in China expect to benefit significantly from the World Health Organization (WHO)’s recent decision to declare monkeypox a “public health emergency” as WHO requested massive orders of monkeypox test kits from shortly after the declaration. at least two such manufacturers, China’s state-owned enterprise Global times reported on Tuesday.

The outlet claimed that at least two Chinese diagnostic test manufacturers, Shanghai-based Liferiver and Taizhou-based Jiangsu Bioperfectus Technologies, received significant numbers of orders for monkeypox test kits within hours of WHO’s announcement on July 23. monkeypox outbreak to constitute “a public health emergency of international concern”.

“A manager with Liferiver, nicknamed Wang, told the Global times on Tuesday [July 26] that the orders came almost at the same time as the WHO declared a health emergency,” the paper reported on Liferiver’s latest request for monkey pox test kits.

“River of Life” […] has received an urgent order from the WHO for reagents for detecting monkeypox nucleic acid, and the products will be delivered to 17 African countries, including Angola, Algeria, Ethiopia and Kenya,” Global times detailed.

The paper further disclosed that Jiangsu Bioperfectus Technologies, another diagnostic test manufacturer based in eastern China’s Taizhou city, also received “an order from the WHO” for monkey pox test kits shortly after the UN’s public health agency’s notification on July 23 regarding the disease.

WHO Director-General Tedros Adhanom Ghebreyesus defied a panel of WHO medical experts to declare monkeypox a “public health emergency” on July 23, despite acknowledging at the time that the disease was a “moderate” threat at worst. of worldwide distribution. The WHO said it had detected more than 16,000 cases of monkey pox in 75 countries and territories by July 23, along with five deaths from the disease. The global outbreak of the disease began around early May.

Fire Island, NY: A Northwell Health employee holds the monkeypox vaccine in Cherry Grove on Fire Island, New York, where monkeypox vaccines were administered on July 14, 2022.  (Photo by James Carbone/Newsday RM via Getty Images)

Fire Island, NY: A Northwell Health employee holds the monkeypox vaccine in Cherry Grove on Fire Island, New York, where monkeypox vaccines were administered on July 14, 2022. (Photo by James Carbone/Newsday RM via Getty Images)

Monkeypox is an infectious disease caused by the monkeypox virus, which, according to the WHO, is a “viral zoonosis” or a “virus transmitted from animals to humans”.

“The monkeypox virus is part of the same family of viruses as the variola virus, the virus that causes smallpox. The symptoms of monkeypox are similar to the symptoms of smallpox, but are milder and monkeypox is rarely fatal,” according to the US Centers for Disease Control and Prevention (CDC).

“While a vaccine has been approved for the prevention of monkeypox, and the traditional smallpox vaccine also provides protection, these vaccines are not widely available and populations around the world under the age of 40 or 50 no longer enjoy the protection afforded by previous vaccines. smallpox vaccination programs,” the WHO noted on May 16.

Leave a Comment